Transmembrane protein 64 reciprocally regulates osteoblast and adipocyte differentiation by modulating Wnt/β-catenin signaling

Bone

Volumn 78, Issue , 2015, Pages 165-173

  Jeong, Byung Chul ^a   Kim, Tae Soo ^b   Kim, Hyun Soo ^c   Lee, Seoung Hoon ^d   Choi, Yongwon ^c  

^a Chonnam National University   (South Korea)

^b Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Wonkwang University   (South Korea)

Author keywords

Adipocyte; Differentiation; Osteoblast; Tmem64; Wnt catenin

Indexed keywords

BETA CATENIN; MEMBRANE PROTEIN; TRANSMEMBRANE PROTEIN 64; UNCLASSIFIED DRUG; WNT PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TMEM64 PROTEIN, MOUSE;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MARROW STROMA CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL NUCLEUS; COLONY FORMING UNIT; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; KNOCKOUT MOUSE; MALE; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TMEM64 GENE; TRANSCRIPTION REGULATION; WILD TYPE; ANIMAL; C3H MOUSE; C57BL MOUSE; CYTOLOGY; GENETICS; HEK293 CELL LINE; METABOLISM; PHYSIOLOGY; STEM CELL; WNT SIGNALING PATHWAY;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; BETA CATENIN; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL DIFFERENTIATION; CELL LINEAGE; CELL NUCLEUS; HEK293 CELLS; HUMANS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOGENESIS; PPAR GAMMA; SIGNAL TRANSDUCTION; STEM CELLS; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84929612584     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2015.05.009     Document Type: Article

References (40)

1. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
2. Ali A.A., Weinstein R.S., Stewart S.A., Parfitt A.M., Manolagas S.C., Jilka R.L. Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. Endocrinology 2005, 146:1226-1235.
3. Bai X.C., Lu D., Bai J., Zheng H., Ke Z.Y., Li X.M., et al. Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochem Biophys Res Commun 2004, 314:197-207.
4. Gimble J.M., Zvonic S., Floyd Z.E., Kassem M., Nuttall M.E. Playing with bone and fat. J Cell Biochem 2006, 98:251-266.
5. Manolagas S.C. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000, 21:115-137.
6. Kolf C.M., Cho E., Tuan R.S. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 2007, 9:204.
7. Monroe D.G., McGee-Lawrence M.E., Oursler M.J., Westendorf J.J. Update on Wnt signaling in bone cell biology and bone disease. Gene 2012, 492:1-18.
8. Iyer S., Ambrogini E., Bartell S.M., Han L., Roberson P.K., de Cabo R., et al. FOXOs attenuate bone formation by suppressing Wnt signaling. J Clin Invest 2013, 123:3409-3419.
9. Zhou H., Mak W., Zheng Y., Dunstan C.R., Seibel M.J. Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling. J Biol Chem 2008, 283:1936-1945.
10. Wu J.Y., Aarnisalo P., Bastepe M., Sinha P., Fulzele K., Selig M.K., et al. Gsalpha enhances commitment of mesenchymal progenitors to the osteoblast lineage but restrains osteoblast differentiation in mice. J Clin Invest 2011, 121:3492-3504.
11. Cawthorn W.P., Bree A.J., Yao Y., Du B., Hemati N., Martinez-Santibanez G., et al. Wnt6, Wnt10a and Wnt10b inhibit adipogenesis and stimulate osteoblastogenesis through a beta-catenin-dependent mechanism. Bone 2012, 50:477-489.
12. Guo W., Flanagan J., Jasuja R., Kirkland J., Jiang L., Bhasin S. The effects of myostatin on adipogenic differentiation of human bone marrow-derived mesenchymal stem cells are mediated through cross-communication between Smad3 and Wnt/beta-catenin signaling pathways. J Biol Chem 2008, 283:9136-9145.
13. Song L., Liu M., Ono N., Bringhurst F.R., Kronenberg H.M., Guo J. Loss of wnt/beta-catenin signaling causes cell fate shift of preosteoblasts from osteoblasts to adipocytes. J Bone Miner Res 2012, 27:2344-2358.
14. Christodoulides C., Laudes M., Cawthorn W.P., Schinner S., Soos M., O'Rahilly S., et al. The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis. J Cell Sci 2006, 119:2613-2620.
15. Kim H., Kim T., Jeong B.C., Cho I.T., Han D., Takegahara N., et al. Tmem64 modulates calcium signaling during RANKL-mediated osteoclast differentiation. Cell Metab 2013, 17:249-260.
16. Jeong B.C., Lee Y.S., Bae I.H., Lee C.H., Shin H.I., Ha H.J., et al. The orphan nuclear receptor SHP is a positive regulator of osteoblastic bone formation. J Bone Miner Res 2010, 25:262-274.
17. Lecanda F., Warlow P.M., Sheikh S., Furlan F., Steinberg T.H., Civitelli R. Connexin43 deficiency causes delayed ossification, craniofacial abnormalities, and osteoblast dysfunction. J Cell Biol 2000, 151:931-944.
18. Heath D.J., Chantry A.D., Buckle C.H., Coulton L., Shaughnessy J.D., Evans H.R., et al. Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma. J Bone Miner Res 2009, 24:425-436.
19. Maretto S., Cordenonsi M., Dupont S., Braghetta P., Broccoli V., Hassan A.B., et al. Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors. Proc Natl Acad Sci U S A 2003, 100:3299-3304.
20. Gambini E., Pompilio G., Biondi A., Alamanni F., Capogrossi M.C., Agrifoglio M., et al. C-kit+cardiac progenitors exhibit mesenchymal markers and preferential cardiovascular commitment. Cardiovasc Res 2011, 89:362-373.
21. Luderer H.F., Bai S., Longmore G.D. The LIM protein LIMD1 influences osteoblast differentiation and function. Exp Cell Res 2008, 314:2884-2894.
22. Hill T.P., Spater D., Taketo M.M., Birchmeier W., Hartmann C. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 2005, 8:727-738.
23. Glass D.A., Bialek P., Ahn J.D., Starbuck M., Patel M.S., Clevers H., et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 2005, 8:751-764.
24. Sen B., Xie Z., Case N., Ma M., Rubin C., Rubin J. Mechanical strain inhibits adipogenesis in mesenchymal stem cells by stimulating a durable beta-catenin signal. Endocrinology 2008, 149:6065-6075.
25. Nishikawa K., Nakashima T., Takeda S., Isogai M., Hamada M., Kimura A., et al. Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiation. J Clin Invest 2010, 120:3455-3465.
26. Akune T., Ohba S., Kamekura S., Yamaguchi M., Chung U.I., Kubota N., et al. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 2004, 113:846-855.
27. Fromigue O., Hay E., Barbara A., Marie P.J. Essential role of nuclear factor of activated T cells (NFAT)-mediated Wnt signaling in osteoblast differentiation induced by strontium ranelate. J Biol Chem 2010, 285:25251-25258.
28. Kawai M., Rosen C.J. PPARgamma: a circadian transcription factor in adipogenesis and osteogenesis. Nat Rev Endocrinol 2010, 6:629-636.
29. Bennett C.N., Longo K.A., Wright W.S., Suva L.J., Lane T.F., Hankenson K.D., et al. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci U S A 2005, 102:3324-3329.
30. Ross S.E., Hemati N., Longo K.A., Bennett C.N., Lucas P.C., Erickson R.L., et al. Inhibition of adipogenesis by Wnt signaling. Science 2000, 289:950-953.
31. Gaur T., Lengner C.J., Hovhannisyan H., Bhat R.A., Bodine P.V., Komm B.S., et al. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 2005, 280:33132-33140.
32. Dong Y.F., Soung do Y., Schwarz E.M., O'Keefe R.J., Drissi H. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor. J Cell Physiol 2006, 208:77-86.
33. Simic P., Zainabadi K., Bell E., Sykes D.B., Saez B., Lotinun S., et al. SIRT1 regulates differentiation of mesenchymal stem cells by deacetylating beta-catenin. EMBO Mol Med 2013, 5:430-440.
34. Chen G., Deng C., Li Y.P. TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 2012, 8:272-288.
35. Marie P.J., Kaabeche K. PPAR gamma activity and control of bone mass in skeletal unloading. PPAR Res 2006, 2006:64807.
36. Zhang L., Su P., Xu C., Chen C., Liang A., Du K., et al. Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARgamma expression and enhancing Runx2 expression. J Pineal Res 2010, 49:364-372.
37. Kawai M., Green C.B., Lecka-Czernik B., Douris N., Gilbert M.R., Kojima S., et al. A circadian-regulated gene, Nocturnin, promotes adipogenesis by stimulating PPAR-gamma nuclear translocation. Proc Natl Acad Sci U S A 2010, 107:10508-10513.
38. Sebert S.P., Lecannu G., Kozlowski F., Siliart B., Bard J.M., Krempf M., et al. Childhood obesity and insulin resistance in a Yucatan mini-piglet model: putative roles of IGF-1 and muscle PPARs in adipose tissue activity and development. Int J Obes (Lond) 2005, 29:324-333.
39. Ichida F., Nishimura R., Hata K., Matsubara T., Ikeda F., Hisada K., et al. Reciprocal roles of MSX2 in regulation of osteoblast and adipocyte differentiation. J Biol Chem 2004, 279:34015-34022.
40. Justesen J., Stenderup K., Ebbesen E.N., Mosekilde L., Steiniche T., Kassem M. Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2001, 2:165-171.